Overview

Baloxavir Versus Oseltamivir for Nursing Home Influenza Outbreaks

Status:
Recruiting
Trial end date:
2023-12-01
Target enrollment:
Participant gender:
Summary
Influenza outbreaks are a prevalent event in nursing homes (NHs). We will study baloxavir compared to oseltamivir when used for influenza prophylaxis when facilities identify an index incident case of influenza. This study will help guide nursing home's decision making and demonstrate the effectiveness of a novel antiviral for preventing influenza outbreaks.
Phase:
Phase 4
Details
Lead Sponsor:
Insight Therapeutics, LLC
Collaborators:
Brown University
Case Western Reserve University
Genentech, Inc.
Treatments:
Baloxavir
Oseltamivir